Abstract
Endoscopic submucosal dissection (ESD) has been accepted as a treatment for early gastric cancer (EGC). However, it is known that the patient after endoscopic treatment of EGC is at risk of synchronous and metachronous multiple cancers, even though initial lesion is completely resected, and there is not enough evidence concerning surveillance strategy after ESD for EGC. The aim of this multicenter study is to clarify the surveillance strategy after ESD by assessing the incidence of multiple cancers during follow-up.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
